FDA tells all GLP-1 makers to warn of vision-loss risk
The FDA told every GLP-1 manufacturer on 9 November to warn of vision-loss risk, naming Ozempic and Wegovy in the class.
What happened1/3 FDA requires vision-loss warning on every GLP-1 drug
The US Food and Drug Administration announced on Monday 9 November 2026 that it is requiring all GLP-1 manufacturers to add a warning about potential vision loss to their drug labels.
The warning covers the entire GLP-1 class, including popular weight-loss drugs like Ozempic and Wegovy. The FDA says these drugs can increase the risk of what the agency calls an "eye stroke."
The announcement was reported by Daniel Wu in The Washington Post. The report does not state when the new labels must appear on shelves.
Why it matters2/3 A US label change, and what it means for a Malaysian reader
This is a US FDA action. It does not automatically change the label on any GLP-1 product sold in Malaysia. Drug labelling here is governed by Malaysia's own regulator under the Ministry of Health.
The FDA flagged a risk increase, not a ban. The drugs remain on the market. What changed is the information on the label.
If you or a family member is on a GLP-1 prescription, the practical step is to bring this news to your next doctor's visit and ask whether it changes your treatment plan.
What to do, step by step3/3 What to do if you or a family member takes a GLP-1
- Check the printed label or patient information leaflet that came with your current GLP-1 prescription. Look for any new warnings about vision or eye-related side effects.
- Book a GP or specialist appointment and bring the FDA announcement. Ask your doctor whether the vision-loss risk changes your situation. Do not stop a prescribed GLP-1 on your own.
- If you bought a GLP-1 product online or from an unregistered seller, stop using it and see a registered pharmacist. Unregistered products carry risks beyond the ones the FDA flagged.
- If you notice any sudden change in vision while on a GLP-1, see an ophthalmologist the same day. Do not wait for a routine check-up.
Questions people ask
Does the FDA vision-loss warning apply to drugs sold in Malaysia?
The FDA regulates drugs sold in the United States. Malaysian drug labels are set by Malaysia's own drug regulator under the Ministry of Health. The FDA action is not binding here, but it is useful information to bring to your doctor or pharmacist.
Should I stop taking Ozempic or Wegovy because of this warning?
Do not stop a prescribed medication without talking to your doctor. The FDA added a warning, not a ban. Your doctor can weigh the vision-loss risk against the benefits for your specific condition.
What is an 'eye stroke'?
The FDA used the term 'eye stroke' in its required warning. The Washington Post report does not define the term or give a frequency for how often it occurs. Ask your doctor or pharmacist what 'eye stroke' means in the context of your medication.
Source: Washingtonpost
